SCHEMBL2807280

SCHEMBL2807280

CC(=CSc1ccc(F)cc1)C(=O)Nc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.47
NPC1 O15118 7/20 0.47
CYP2C19 P33261 2/20 0.47
NAPRT Q6XQN6 1/20 0.46
HSD17B10 Q99714 1/20 0.46
MAPT P10636 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
POLB P06746 4/20 0.42
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
TAAR1 Q96RJ0 1/20 0.41
MAOB P27338 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
EGFR P00533 1/20 0.41
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2807273 1.00 RAB9A (0.47) RAB9ANPC1CYP2C19NAPRTHSD17B10
SCHEMBL2812834 0.90 HSD17B10 (0.53) RAB9ANPC1NAPRTHSD17B10MAPT
SCHEMBL2812831 0.90 HSD17B10 (0.53) RAB9ANPC1NAPRTHSD17B10MAPT
SCHEMBL2813325 0.87 TDP1 (0.47) RAB9ANPC1CYP2C19MAPTSMN1; SMN2
SCHEMBL2813320 0.87 TDP1 (0.47) RAB9ANPC1CYP2C19MAPTSMN1; SMN2
SCHEMBL2810265 0.87 NAPRT (0.47) RAB9ANPC1NAPRTHSD17B10MAPT
SCHEMBL2810262 0.87 NAPRT (0.47) RAB9ANPC1NAPRTHSD17B10MAPT
SCHEMBL2809174 0.86 RAB9A (0.47) RAB9ANPC1CYP2C19NAPRTHSD17B10
SCHEMBL2809170 0.86 RAB9A (0.47) RAB9ANPC1CYP2C19NAPRTHSD17B10
SCHEMBL2808537 0.84 RAB9A (0.45) RAB9ANPC1CYP2C19MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 RAB9A 1842/4885NPC1 3668/4885CYP2C19 1208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.